Current KL2 Scholars
The ICTR Research Education and Career Development Core (ICTR-REC) is pleased to announce the selection of eight new
scholars for the ICTR KL2 Scholars Program beginning June 1, 2009.
The 2006 & 2007 cohorts of scholars were formerly with the NCRR Roadmap K12, known at UW as the Training and Education to Advance Multidisciplinary (TEAM) Clinical Research Program.
Cohort 5 - 2009 | Cohort 4 - 2008 | Cohort 3 - 2007 | Cohort 2 - 2006
Cohort 5 (2009)
Mark Burkard completed his MD and Ph.D. in Chemistry at the University of Rochester. His post-graduate training in Internal Medicine was undertaken at Cornell University and in Medical Oncology at Sloan-Kettering Cancer Center. Dr. Burkard is currently Assistant Professor in the Department of Medicine, with a clinical focus on medical management of breast cancer. His research interest is optimizing kinase-targeted therapeutics for use in treating breast cancer. His laboratory uses a combination of genetic and pharmacology tools to elucidate kinase biology and identify therapeutic strategies for treating cancer, based on the specific genetic alterations they harbor. Dr. Burkard participates in the Breast Cancer Disease Oriented Working Group and the Phase I clinical research program.
Dr. Burkard's mentors are George Wilding, MD (Hematology-Oncology and Comprehensive Cancer Center) and F. Michael Hoffman, PhD (Chair of Oncology).
Erin Costanzo received her PhD in Clinical Psychology from the University of Iowa in 2006. She completed her clinical internship in Health Psychology at the University of Wisconsin Hospital and Clinics and a clinical fellowship in Cancer Psychology at the UW Carbone Comprehensive Cancer Center (UWCCC). She also completed a postdoctoral fellowship with the UW Training Program in Emotion Research which focused on emotional processes in both psychological adjustment to cancer and biological processes associated with cancer. Dr. Costanzo is currently an Assistant Professor (CHS) in the Department of Psychiatry. Her research focuses on contributions of psychosocial factors to cancer outcomes and the biobehavioral mechanisms underlying these relationships. She is presently investigating the extent to which psychological risk and resilience factors may hinder or facilitate immune reconstitution following hematopoietic stem cell transplantation. Her long-term goal is to translate findings into targeted psychosocial interventions to improve the health and quality of life of individuals with cancer. Dr. Costanzo also provides clinical care to cancer patients and their families at the UWCCC.
Dr. Costanzo's mentors are Christopher Coe, PhD (Psychology and the Waisman Center) and Mark Juckett, MD (Hematology-Oncology).
Peter Ferrazzano received his MD from Saint Louis University School of Medicine. He then completed a combined Internal Medicine and Pediatrics Residency at New York Medical College, followed by fellowship training in Pediatric Critical Care Medicine at Columbia University. He is currently an Assistant Professor of Pediatrics in the School of Medicine and Public Health. Dr. Ferrazzano’s research interest is in pediatric brain injury and neuroprotection. His current work uses small animal MRI to identify biomarkers of injury and therapeutic effect in animal models of pediatric cerebral ischemia. A combination of real-time imaging, conventional longitudinal imaging, and rodent behavioral testing is used to comprehensively assess neuro-developmental differences in the physiology of ischemia and reperfusion, and the response to neuroprotective interventions. In an effort to improve clinical outcomes and to create a framework for translating neuroprotective interventions, he is also developing a clinical pediatric brain injury database which will correlate in-patient clinical data with follow-up neurodevelopmental assessments performed at the Waisman Center.
Dr. Ferrazzano's mentors are Dandan Sun, MD, PhD (Neurological Surgery) and Beth Meyerand, PhD (Medical Physics).
Colleen Mahoney earned her Ph.D. from the University of Chicago’s School of Social Service Administration and is now an Assistant Professor in the School of Social Work. Prior to her doctoral studies, she worked as a clinical social worker with adults with serious mental illness in community-based settings in Chicago and Washington, D.C. Dr. Mahoney studies interpersonal processes involved in service delivery for persons with serious mental illness, and she is specifically concerned with how these processes relate to treatment adherence issues and client outcomes. Her previous research has examined how providers conceptualize their treatment relationships with clients and how their clinical reasoning about clients’ medication nonadherence impacts the quality of these treatment relationships. Dr. Mahoney’s current research includes a series of studies that observe client-provider communication about medication issues in order to conceptualize and measure the interpersonal processes involved in the treatment task of medication management and to relate these processes to client outcomes.
Dr. Mahoney's mentors are Jan Greenberg, PhD (Director of Social Work) and Betty Chewning, PhD (Pharmacy).
Joshua Mezrich earned his undergraduate AB degree from Princeton University as a Slavic Language and Literature major in 1993, and an MD from Cornell University in New York in 1997. He completed a general surgery residency at the University of Chicago in 2005, and spent three extra years during his residency at the Transplant Biology Research Center at the Massachusetts General Hospital, performing a research fellowship in transplant biology. He then completed a transplant surgery fellowship at the University of Wisconsin-Madison. Dr. Mezrich is currently an assistant professor in the School of Medicine and Public Health, and performs abdominal transplants at the UW Hospital. His research project focuses on the role of the aryl hydrocarbon receptor, the receptor for the toxin dioxin, in causing immunosuppression, thymic involution, and generation of T Regulatory Cells. This receptor may be a novel target for modulation in efforts to generate tolerance in solid organ transplantation. He conducts his research in the McArdle Laboratory for Cancer Research.
Dr. Mezrich's mentors are Christopher Bradfield, PhD (Oncology) and William Sugden, PhD (Oncology).
Enid Montague received MS and PhD degrees in Industrial and Systems Engineering from Virginia Tech in 2008, specializing in human factors and ergonomics engineering, the future professoriate, women’s studies and human computer interaction. Prior to attending Virginia Tech, she was a research assistant at Eastern Virginia Medical School’s Glennan Center for Geriatrics, the Virginia Modeling and Simulation Center and Old Dominion University’s Department of Psychology. Dr. Montague is currently an Assistant Professor of Industrial Engineering and Fellow at the University of Wisconsin-Madison College of Engineering. She has received fellowships from the Southern Regional Education Board and the Francis Research Fellowship for research that emphasizes “longer, safer and healthier lives” for her research “Understanding Trust in Medical Technology.” Dr. Montague’s research uses industrial and human factors engineering methodologies, design principles and theories to understand health care systems to promote patient and worker safety. At present, Dr. Montague explores the role of trust between people and technologies in health care work systems; she looks at organizational and design factors that effect both workers and patients.
Dr. Montague's mentors are Pascale Carayon, PhD (Industrial Engineering and Population Health Sciences) and Ben-Tzion Karsh, PhD (Industrial Engineering and Population Health Sciences).
Rekha Ramamurthy earned her MD from the University of Chicago, Pritzker School of Medicine. She completed her Internal Medicine Residency at the University of Pittsburgh and her Fellowship in Endocrinology, Diabetes and Metabolism at Northwestern University, Feinberg School of Medicine. She is currently an Assistant Professor of Medicine (CHS) in the Section of Endocrinology, Diabetes and Metabolism within the School of Medicine and Public Health. During her Endocrinology Fellowship, she focused her research activities on the metabolic complications of PCOS. Since joining UW, her area of research interest has been in vitamin D related health consequences at the UW Osteoporosis Clinical Research Center, where she is also involved in a number of industry-sponsored and investigator-initiated clinical trials. She is conducting a clinical trial examining the effects of vitamin D on cardiovascular health.
Dr. Ramamurthy's mentors are Neil Binkley, MD (Medicine and Institute on Aging) and James Gern, MD (Pediatrics).
Timothy Stein received his DVM from Iowa State University and his PhD from the University of Wisconsin-Madison. He will be completing his medical oncology residency at the University of Wisconsin-Madison in July and will be an Assistant Professor in the Department of Medical Sciences within the School of Veterinary Medicine. His research interests are in the generation and characterization of animal models of cancer, specifically liver cancer and bone tumors (osteosarcoma). A portion of his research utilizes transgenic mouse models to better characterize the contribution of specific gene alterations in liver cancer. His current research will focus on characterizing naturally-occurring canine osteosarcoma associated with increased alkaline phosphatase concentrations (a negative prognostic indicator in dogs and humans) using microarray analysis and cell culture techniques.
Dr. Stein's mentors are David Vail, PhD (Veterinary Medicine Medical Sciences and Comprehensive Cancer Center) and John Svaren, PhD (Veterinary Medicine Comparative Biosciences and Neurological Surgery).
Cohort 4 (2008)
ICTR Dean's Scholars
Marcia Slattery received her MD from the University of Wisconsin School of Medicine and Public Health and her MHS from Duke University School of Medicine. She completed a Psychiatry residency and a Child and Adolescent Psychiatry fellowship at the Mayo Clinic. She is currently an Associate Professor (CHS) in Psychiatry and Pediatrics. Dr. Slattery’s research interests are focused on neurobiological mechanisms associated with anxiety disorders in children and adolescents including alterations in immune and pituitary-adrenal systems, and brain functional changes. She is particularly interested in the impact of stress on HPA, immune, and brain functioning in youth with anxiety.
Judith Smith earned her MD and PhD in Immunology at the University of Chicago. From there, she completed her Pediatric residency and fellowship in Pediatric Rheumatology at the Cincinnati Children’s Hospital. Since she joined the Department of Pediatrics as an Assistant Professor in 2006, she has pursued a basic research program aimed at learning how intracellular stress responses shape inflammatory cytokine responses. Her projects range in scope from basic regulation of cytokine gene transcription to in vivo models involving endoplasmic reticulum stress and analysis of patient samples for ER stress and inflammatory cytokine production. Dr. Smith also remains actively involved in the care of pediatric patients with Rheumatologic conditions.
Cohort 3 (2007)
Christie Bartels graduated in 2001 with her MD from Creighton University and completed Internal Medicine residency, chief residency, and fellowship studies in Rheumatology at the University of Wisconsin. She is now a Clinical Instructor in the section of Rheumatology and is pursuing a master’s in Population Health Sciences at the University of Wisconsin. Dr. Bartels’ research focuses on long-term outcomes of rheumatoid arthritis (RA) and systemic lupus, examining disease-specific complications and coronary artery disease. She is completing work examining the impact of modern treatments called “biologic agents” on the spectrum of systemic rheumatoid arthritis complications called extra-articular manifestations. Another current study is examining the cardiovascular morbidity and mortality among rural lupus patients. Ultimately Dr. Bartels aims to translate an understanding of long-term complications in RA and lupus into interventions to reduce the mortality gap seen in patients with systemic inflammatory diseases.
Angela Byars-Winston received bachelor’s degrees in Psychology and Spanish Literature and a master's degree in Counselor Education from San Diego State University. She completed a pre-doctoral clinical internship at the University of Maryland, College Park and received her PhD in Counseling Psychology from Arizona State University. She joined the Department of Counseling Psychology faculty at UW-Madison in 1997 and is currently an Associate Scientist in the UW School of Medicine and Public Health. Dr. Byars-Winston’s research interests include the examination of cultural influences on career development, especially for racial/ethnic minorities and women, using social cognitive approaches. As the project director for a research grant from the Alfred P. Sloan Foundation, she is conducting a three-year study of the career and academic development of racial/ethnic minority undergraduates in Engineering and the Life Sciences at the University of Wisconsin-Madison.
Michael Hammer earned his PhD from the University of Kansas, majoring in Speech Physiology and Neuroscience. He completed his bachelor of Music and graduate work in Voice Performance, his master’s degree in Clinical Speech Language Pathology at the University of Missouri-Kansas City. He is currently an Assistant Scientist in the section of Otolaryngology. Dr. Hammer is interested in the neural mechanisms of upper airway sensorimotor control, with an aim to translate new knowledge into more effective neurorehabilitation approaches. He recently completed a set of studies exploring sensory and motor aspects of laryngeal control related to cough, speech, swallow, and voice, and how these important functions of the upper airway are affected in aging and Parkinson’s disease. Dr. Hammer is a certified speech language pathologist with primary clinical experience in respiratory, speech, swallow, and voice disorders related to aging, head & neck cancer, neuropathology, and occupational voice.
Jeremy Johnson earned his PharmD from the University of Wisconsin School of Pharmacy and his bachelor of science degree in Biology from the University of Wisconsin-Stevens Point. He is currently an Assistant Scientist in the School of Pharmacy. Dr. Johnson is interested in the area of experimental therapeutics and its application to cancer chemoprevention. His research focus is on the use of naturally occurring compounds that have shown promise as cancer chemopreventive agents in pre-clinical settings and helping to facilitate the translation of these compounds to clinical practices. Currently, Dr. Johnson is working with two compounds that have shown promise as cancer chemopreventive agents in cancer cell culture models and cancer animal models. With previous experience in pre-clinical research that includes cell culture, animal experiments as well as basic molecular biology techniques, Dr. Johnson is analyzing and assessing available data to help design and initiate a phase I human clinical trial.
Jana Jones received her PhD in Rehabilitation Psychology from the University of Wisconsin-Madison. She completed her pre-doctoral internship at St. Charles Hospital and Rehabilitation Center in Port Jefferson, NY and completed a postdoctoral fellowship in Neuropsychology in the Department of Neurology at the University of Wisconsin. She completed a bachelor's degree in Psychology and History and a master’s degree in Rehabilitation Counseling at the University of Texas. Dr. Jones is currently an Assistant Professor (CHS) in the Department of Neurology. Her research interests are in the field of epilepsy and include psychosocial outcomes following anterior temporal lobectomy in adults and psychiatric comorbidity in adults and children with epilepsy.
Karen Kehl earned her PhD in Nursing from UW-Madison. She received her undergraduate degree in Nursing from UW-Madison and her master's degree in Nursing from Rush University. Dr. Kehl has been a nurse for more than 20 years and has specialized in hospice and palliative care for more than 15 years. She is currently a Research Associate in the School of Nursing. Dr. Kehl’s research focus is preparing hospice families for death in the home, with the goal of developing a tailored intervention which will take into account the patient's condition and the family's needs. She is particularly interested in preparing rural families for the final hours of life. Dr. Kehl is currently working on a number of projects related to preparing families for the last hours of life. She is analyzing data from a study examining the written preparatory materials used by hospices across the country to see if there are local or regional variations in the material presented. She is conducting a study to determine when and how hospice professionals provide preparatory information to hospice families.
Amy Jo Haavisto Kind graduated in 2001 with her MD from the University of Wisconsin Medical School. She completed an Internal Medicine-Primary Care residency at Massachusetts General Hospital in Boston, returning to the University of Wisconsin in 2004 to complete a clinical fellowship in Geriatric Medicine and a VA research fellowship in Older Women’s Health. Dr. Kind is also pursuing a PhD degree in Population Health Sciences, focusing on health services research. As a Clinical Instructor in Geriatrics, Dr. Kind’s research focuses on patient safety during transitions between health care settings. Her goal is to improve the hospital discharge process to enhance patient safety, especially for geriatric and nursing home populations. Currently she has projects exploring the relationship between discharge summary documentation and patient outcomes, including bounce-back risk, in hospitalized patients discharged to nursing homes.
Megan Piper earned her PhD in Clinical Psychology from the University of Wisconsin. Dr. Piper graduated from Carleton College in Minnesota with a degree in Chemistry and earned her master’s in Clinical Psychology from Miami University in Ohio where she concentrated on alcohol research. She is an Assistant Scientist at the University of Wisconsin Center for Tobacco Research and Intervention. Dr. Piper’s research focuses on identifying and treating tobacco dependence. Some specific projects she is currently working on include: identifying a unique group of smokers with a distinct dependence profile; linking early daily smoking and genetic variants with increased risk for tobacco dependence; and the efficacy of different smoking cessation treatments and the mechanisms via which these treatments exert their effects. She is also interested in the role of psychiatric comorbidity and tobacco dependence and is working on a project using structured clinical interview data from the Wisconsin Smokers’ Health Study to examine how mental health issues are related to tobacco dependence and ability to quit smoking.
Cohort 2 (2006)
Michele Ries earned her master’s and doctoral degrees in Clinical Psychology from the University of Memphis and completed her internship training in Clinical Neuropsychology at the University of Chicago. Dr. Ries is currently an Assistant Scientist in the section of Geriatrics. She conducts research using MRI methods to detect structural and functional brain changes in individuals at risk for developing Alzheimer’s disease (AD). One of her research foci targets brain changes in asymptomatic middle-aged individuals with varying AD-risk due to genetic factors and parental history of AD. Another research focus relates to brain changes accompanying memory deficits and impaired awareness of memory deficits in patients with Mild Cognitive Impairment, a major risk factor for AD. Given their putative role in memory and self-awareness and their vulnerability to changes in AD, specific brain regions of interest in this neuroimaging research include the ventromedial prefrontal cortex and posterior cingulate cortex. Dr. Ries grew up just north of Baltimore, MD and completed her undergraduate degree in Psychology with honors while on a Full Presidential Academic Scholarship at the College of Notre Dame of Maryland.
Orly Vardeny earned her PharmD degree from the University of Utah. She completed a residency in Ambulatory Care from the University of Utah Hospital and Clinics, followed by a research fellowship in Experimental Cardiovascular Pharmacotherapy. Dr. Vardeny is currently an Assistant Professor (CHS) in the School of Pharmacy. Dr. Vardeny conducts research in chronic heart failure, focusing on delineating contributions of beta adrenergic pathways on metabolic abnormalities and immune dysfunction in patients with heart failure. She currently studies associations of beta2 adrenergic receptor polymorphisms and their interactions with medications used in heart failure on insulin resistance in these patients. Additionally, she investigates beta adrenergic mechanisms of immune responses to influenza vaccination, and studies alternative immunization strategies to improve protection from influenza infection in heart failure patients.